Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002002369 | SCV002233848 | pathogenic | Joubert syndrome 8 | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn311Lysfs*2) in the ARL13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARL13B are known to be pathogenic (PMID: 18674751). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ARL13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1453361). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002002369 | SCV005664310 | likely pathogenic | Joubert syndrome 8 | 2024-03-08 | criteria provided, single submitter | clinical testing |